Advertisement

Topics

Celltrion And Teva Say FDA Accepts BLA For Proposed Biosimilar To Herceptin

08:26 EDT 31 Jul 2017 | FinanzNachrichten

PETAH TIKVA (dpa-AFX) - Celltrion Inc. and Teva Pharmaceutical Industries Ltd. (TEVA) said that the U.S. Food and Drug Administration has accepted for review the Biologics License Application for ...

Original Article: Celltrion And Teva Say FDA Accepts BLA For Proposed Biosimilar To Herceptin

NEXT ARTICLE

More From BioPortfolio on "Celltrion And Teva Say FDA Accepts BLA For Proposed Biosimilar To Herceptin"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...